Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousRejuvenationTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesTreatment OutcomeGraft vs Tumor EffectCombined Modality TherapySkin AgingHematopoietic Stem Cell TransplantationAnemia, AplasticCyclophosphamideSurgery, PlasticLeukemiaDermatologyLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingRecurrenceHematopoietic Stem CellsHistocompatibilityBone Marrow DiseasesTime FactorsTransplantation, IsogeneicSurvival AnalysisRetrospective StudiesKidney TransplantationPrognosisLaser TherapyHematopoiesisImmunosuppressive AgentsSurvival RateLeukemia, Myeloid, AcuteFatal OutcomeMice, Inbred C57BLVidarabineDisease-Free SurvivalRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationAcute DiseaseHematologic NeoplasmsLymphoma, Non-HodgkinRemission InductionChemotherapy, AdjuvantGraft RejectionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyStem Cell TransplantationGraft vs Host ReactionImmunosuppressionMethotrexateLymphocyte DepletionLeukocyte TransfusionEtoposideAntineoplastic AgentsHeart TransplantationHodgkin DiseaseMyelodysplastic SyndromesActuarial AnalysisSevere Combined ImmunodeficiencyColony-Forming Units AssayT-LymphocytesHematologic DiseasesCytarabineCarmustineChimeraHLA AntigensDoxorubicinProspective StudiesLung TransplantationCyclosporineBone DensityGranulocyte Colony-Stimulating FactorLymphocyte TransfusionMelphalanNuclear FamilyLeukocyte CountPancytopeniaOrgan TransplantationLymphomaCell DifferentiationRisk FactorsGraft vs Leukemia EffectMultiple Myeloma